作者回应：脓毒症免疫调节治疗的见解
Author Response: Insights into Immunomodulatory Therapy for Sepsis.
作者信息
Ghosh Indranil, Sangha Sukhwinder S, Pandey Gaurav, Srivastava Atul
机构信息
Department of Medicine and Nephrology, Army Hospital (R & R), New Delhi, India.
Department of Medicine and Nephrology, Command Hospital, Chandimandir, Panchkula, Haryana, India.
出版信息
Indian J Crit Care Med. 2025 Jan;29(1):91. doi: 10.5005/jp-journals-10071-24874. Epub 2024 Dec 30.
Abstract
Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response: Insights into Immunomodulatory Therapy for Sepsis. Indian J Crit Care Med 2025;29(1):91.
摘要
戈什I、桑加SS、潘迪G、斯里瓦斯塔瓦A。作者回复：脓毒症免疫调节治疗的见解。《印度重症监护医学杂志》2025年；29(1)：91。
相似文献
1
Author Response: Insights into Immunomodulatory Therapy for Sepsis.作者回应：脓毒症免疫调节治疗的见解
Indian J Crit Care Med. 2025 Jan;29(1):91. doi: 10.5005/jp-journals-10071-24874. Epub 2024 Dec 30.
2
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.多黏菌素B血液灌流治疗脓毒症的疗效
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
3
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.脓毒症新型免疫调节疗法的关键见解：在局限性中评估前景。
Indian J Crit Care Med. 2025 Jan;29(1):90. doi: 10.5005/jp-journals-10071-24847. Epub 2024 Dec 30.
4
Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?脓毒症中多黏菌素B血液灌流：黑暗中的一线曙光？
Indian J Crit Care Med. 2024 Oct;28(10):903-905. doi: 10.5005/jp-journals-10071-24816. Epub 2024 Sep 30.
5
The Sepsis Score Dilemma: Balancing Precision and Utility.脓毒症评分困境：平衡精准性与实用性
Indian J Crit Care Med. 2024 Oct;28(10):906-907. doi: 10.5005/jp-journals-10071-24814. Epub 2024 Sep 30.
6
To C or not to C? Designing a Pragmatic Trial to Deploy a Novel Immunomodulatory Therapy to Fight Organ Dysfunction in Sepsis.是选择C还是不选C？设计一项务实试验以应用新型免疫调节疗法对抗脓毒症中的器官功能障碍。
Indian J Crit Care Med. 2024 Mar;28(3):311. doi: 10.5005/jp-journals-10071-24636.
7
Author Response.作者回复。
Indian J Crit Care Med. 2024 Apr;28(4):408-409. doi: 10.5005/jp-journals-10071-24685.
8
Author Reply: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study.作者回复：去甲肾上腺素与特利加压素联合去甲肾上腺素治疗感染性休克的比较：一项随机对照研究。
Indian J Crit Care Med. 2023 Aug;27(8):603-604. doi: 10.5005/jp-journals-10071-24514.
9
Extracorporeal Therapy in Sepsis.脓毒症的体外治疗
Indian J Crit Care Med. 2020 Apr;24(Suppl 3):S117-S121. doi: 10.5005/jp-journals-10071-23382.
10
Author Response: Appropriately Designed Studies are Needed before Thiamine and Vitamin C Plus Hydrocortisone are Judged Nonbeneficial in Septic Shock.作者回复：在判定硫胺素、维生素C加氢化可的松对感染性休克无益处之前，需要进行设计合理的研究。
Indian J Crit Care Med. 2025 Feb;29(2):193-194. doi: 10.5005/jp-journals-10071-24902. Epub 2024 Dec 30.
本文引用的文献
1
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.多黏菌素B血液灌流治疗脓毒症的疗效
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
2
Approach to Intensive Care Costing and Provision of Cost-effective Care.重症监护成本核算及提供具有成本效益的护理的方法。
Indian J Crit Care Med. 2023 Dec;27(12):876-887. doi: 10.5005/jp-journals-10071-24576.
3
COST OF INTENSIVE CARE IN INDIA.印度重症监护的成本
Int J Technol Assess Health Care. 2016 Jan;32(4):241-245. doi: 10.1017/S0266462316000398. Epub 2016 Sep 9.
4
Daily cost of an intensive care unit day: the contribution of mechanical ventilation.重症监护病房每日费用：机械通气的影响因素
Crit Care Med. 2005 Jun;33(6):1266-71. doi: 10.1097/01.ccm.0000164543.14619.00.
Zotero 插件